These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 961500)

  • 41. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid in children with afebrile and febrile convulsions.
    Habel A; Yates CM; McQueen JK; Blackwood D; Elton RA
    Neurology; 1981 Apr; 31(4):488-91. PubMed ID: 6164017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
    Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
    Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus.
    Gopal SC; Pandey A; Das I; Gangopadhyay AN; Upadhyaya VD; Chansuria JP; Singh TB
    Childs Nerv Syst; 2008 Jun; 24(6):713-6. PubMed ID: 18075745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
    Jennings WS; Schulz SC; Narasimhachari N; Hamer RM; Friedel RO
    Psychiatry Res; 1985 Oct; 16(2):87-94. PubMed ID: 2415997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man.
    Jakupcević M; Lacković Z; Stefoski D; Bulat M
    J Neurol Sci; 1977 Mar; 31(2):165-71. PubMed ID: 839230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CSF levels of cyclic nucleotides and adrenergic metabolites in malignant gliomas.
    Gerosa MA; Olivi A; Longatti PL; Teolato S; Carteri A
    Surg Neurol; 1980 May; 13(5):359-62. PubMed ID: 6155709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CSF HVA and 5-HIAA.
    Wood JH
    Neurology; 1979 Jun; 29(6):910-12. PubMed ID: 572023
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cerebral mediators and intracranial neoplasms].
    Collice M; Porta M; Ferrara M; Castelli A
    Acta Neurol (Napoli); 1975; 30(1):71-7. PubMed ID: 1225028
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
    Wode-Helgodt B; Fyrö B; Gullberg B; Sedvall G
    Acta Psychiatr Scand; 1977 Aug; 56(2):129-42. PubMed ID: 899844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC; Wode-Helgodt B
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period.
    Silverstein FS; Donn S; Buchanan K; Johnston MV
    J Neurochem; 1984 Dec; 43(6):1769-72. PubMed ID: 6208340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
    Narayan M; Srinath S; Anderson GM; Meundi DB
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
    Tabaddor K; Wolfson LI; Sharpless NS
    Neurology; 1978 Dec; 28(12):1249-53. PubMed ID: 569783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.